LAS 34917
Latest Information Update: 09 Dec 2003
At a glance
- Originator Almirall-Prodesfarma
- Class Male infertility therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Erectile dysfunction
Most Recent Events
- 09 Dec 2003 No development reported - Preclinical for Erectile dysfunction in Spain (unspecified route)
- 30 Jul 2001 New profile
- 30 Jul 2001 Preclinical development for Erectile dysfunction in Spain (Unknown route)